Majid Ahmadi

5.9k total citations · 1 hit paper
103 papers, 4.2k citations indexed

About

Majid Ahmadi is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Majid Ahmadi has authored 103 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 40 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in Majid Ahmadi's work include Reproductive System and Pregnancy (17 papers), MicroRNA in disease regulation (15 papers) and Immune Cell Function and Interaction (14 papers). Majid Ahmadi is often cited by papers focused on Reproductive System and Pregnancy (17 papers), MicroRNA in disease regulation (15 papers) and Immune Cell Function and Interaction (14 papers). Majid Ahmadi collaborates with scholars based in Iran, Russia and Iraq. Majid Ahmadi's co-authors include Mehdi Yousefi, Sanam Dolati, Leili Aghebati‐Maleki, Farhad Jadidi‐Niaragh, Mohammad Nouri, Leila Roshangar, Mahnaz Ghaebi, Hamed Valizadeh, Davoud Rostamzadeh and Zohreh Babaloo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Life Sciences.

In The Last Decade

Majid Ahmadi

100 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers

2019 328 citations Ali Aghebati‐Maleki, Sanam Dolati et al. Journal of Cellular Physiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Majid Ahmadi Iran	40	1.3k	1.3k	479	454	443	103	4.2k
Leili Aghebati‐Maleki Iran	47	2.4k 1.9×	1.9k 1.5×	641 1.3×	954 2.1×	652 1.5×	219	6.4k
Mohammad Nouri Iran	46	2.4k 1.8×	1.4k 1.1×	813 1.7×	532 1.2×	624 1.4×	272	6.6k
Sanam Dolati Iran	31	899 0.7×	845 0.7×	330 0.7×	207 0.5×	321 0.7×	93	2.9k
Rashmin C. Savani United States	46	2.6k 2.0×	880 0.7×	445 0.9×	411 0.9×	233 0.5×	113	6.6k
Jing Hua China	46	2.7k 2.1×	1.4k 1.1×	569 1.2×	780 1.7×	139 0.3×	215	7.3k
Saeed Mohammadian Haftcheshmeh Iran	17	1.6k 1.2×	2.0k 1.6×	403 0.8×	484 1.1×	87 0.2×	43	4.7k
Weiwei Wang China	38	2.5k 1.9×	420 0.3×	867 1.8×	660 1.5×	167 0.4×	283	5.6k
Yu Xiao China	40	2.4k 1.8×	615 0.5×	1.3k 2.7×	855 1.9×	148 0.3×	207	5.8k
Myungshin Kim South Korea	32	1.4k 1.1×	490 0.4×	337 0.7×	544 1.2×	96 0.2×	358	4.4k
Abbas Shapouri Moghaddam Iran	16	1.5k 1.2×	1.9k 1.5×	475 1.0×	446 1.0×	110 0.2×	33	4.5k

Countries citing papers authored by Majid Ahmadi

Since Specialization

Citations

This map shows the geographic impact of Majid Ahmadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majid Ahmadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majid Ahmadi more than expected).

Fields of papers citing papers by Majid Ahmadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Majid Ahmadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majid Ahmadi. The network helps show where Majid Ahmadi may publish in the future.

Co-authorship network of co-authors of Majid Ahmadi

This figure shows the co-authorship network connecting the top 25 collaborators of Majid Ahmadi. A scholar is included among the top collaborators of Majid Ahmadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majid Ahmadi. Majid Ahmadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malekpour, Kosar, Ali Hazrati, Sara Soudi, et al.. (2023). Combinational administration of mesenchymal stem cell-derived exosomes and metformin reduces inflammatory responses in an in vitro model of insulin resistance in HepG2 cells. Heliyon. 9(5). e15489–e15489. 9 indexed citations

Ghaleh, Hadi Esmaeili Gouvarchin, Morteza Izadi, Mohammad Javanbakht, et al.. (2023). Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacology. 31(6). 3029–3036. 3 indexed citations

Ghorbani, Farzaneh, Majid Ahmadi, Ali Aghebati‐Maleki, et al.. (2022). Evaluating the effects of autologous platelet lysate on gene expression of bone growth factors and related cytokines secretion in rabbits with bone fracture. Gene Reports. 28. 101658–101658. 1 indexed citations

Jalil, Abduladheem Turki, Walid Kamal Abdelbasset, Alexei Valerievich Yumashev, et al.. (2021). Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies. DNA repair. 107. 103203–103203. 39 indexed citations

Shabgah, Arezoo Gowhari, Fatemeh Ezzatifar, A. Surendar, et al.. (2021). Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy. IUBMB Life. 73(4). 659–669. 44 indexed citations

Firouzi‐Amandi, Akram, et al.. (2021). Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients. Journal of Drug Delivery Science and Technology. 67. 102967–102967. 24 indexed citations

Karpisheh, Vahid, Balsam Qubais Saeed, Angelina Olegovna Zekiy, et al.. (2021). Different T cell related immunological profiles in COVID-19 patients compared to healthy controls. International Immunopharmacology. 97. 107828–107828. 28 indexed citations

Surendar, A., et al.. (2021). Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature. Cancer Cell International. 21(1). 158–158. 52 indexed citations

Sadeghi, Armin, Safa Tahmasebi, Arshad Mahmood, et al.. (2020). Expression of Concern: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls. Journal of Cellular Physiology. 236(4). 2829–2839. 127 indexed citations

10.

Aghebati‐Maleki, Ali, Sanam Dolati, Majid Ahmadi, et al.. (2019). Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Journal of Cellular Physiology. 235(3). 1962–1972. 328 indexed citations breakdown →

11.

Rostamzadeh, Davoud, Mehdi Yousefi, Mohammad Reza Haghshenas, et al.. (2019). mTOR Signaling pathway as a master regulator of memory CD8⁺ T‐cells, Th17, and NK cells development and their functional properties. Journal of Cellular Physiology. 234(8). 12353–12368. 46 indexed citations

12.

Azizi, Ramyar, Majid Ahmadi, Shahla Danaii, et al.. (2019). Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1/Th2 ratio. Journal of Cellular Physiology. 234(10). 19039–19047. 42 indexed citations

13.

Ghaebi, Mahnaz, Samaneh Abdolmohammadi‐Vahid, Majid Ahmadi, et al.. (2018). T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. Journal of Reproductive Immunology. 131. 21–29. 58 indexed citations

14.

Eghbal‐Fard, Shadi, Mehdi Yousefi, Majid Ahmadi, et al.. (2018). The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. Journal of Cellular Physiology. 234(4). 5106–5116. 106 indexed citations

15.

Aghebati‐Maleki, Leili, Sanam Dolati, Ali Fotouhi, et al.. (2018). Prospect of mesenchymal stem cells in therapy of osteoporosis: A review. Journal of Cellular Physiology. 234(6). 8570–8578. 83 indexed citations

16.

Afkham, Amir, Leili Aghebati‐Maleki, Homayoon Siahmansouri, et al.. (2017). Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer. Pharmacological Reports. 70(3). 418–425. 29 indexed citations

17.

Motallebnezhad, Morteza, Vahid Younesi, Leili Aghebati‐Maleki, et al.. (2016). Antiproliferative and apoptotic effects of a specific anti-insulin-like growth factor I receptor single chain antibody on breast cancer cells. Tumor Biology. 37(11). 14841–14850. 6 indexed citations

18.

Ahmadi, Majid, et al.. (2016). Study of ASXL1 gene mutation in Chronic Myelogenous Leukemia. Scientific Journal of Iran Blood Transfus Organ. 13(4). 324–332. 2 indexed citations

19.

Majidi, Jafar, et al.. (2016). Polyclonal Antibody Production against Mouse Purified IgG2a towards Use in Basic Research. SHILAP Revista de lepidopterología. 4(1). 30–35. 2 indexed citations

20.

Ahmadi, Majid, et al.. (2004). HEPATITIS C IN BLOOD PRODUCTS RECEIVERS. Iranian Journal of Pediatrics. 14(1). 15–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact